Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.

from Reuters: Business News http://ift.tt/1NuYP1A